Patent medicines originated in England in the mid 17th century and were marketed with extravagant claims, offering cures for a host of maladies. Recommendations for dosage were vague, and ingredients (often including opium) were usually not specified. In 1726 Benjamin Okell was granted the royal patent for Dr. Bateman’s Pectoral Drops, a tincture of gambir (an astringent extract from an Asian plant) and opium. Advertisements published in the London Mercury as early as 1721 directed prospective customers to the warehouse and printing shop at Bow's Churchyard, where they could purchase the drops for one shilling. Our copy of the 1731 reprint by Peter Zenger is likely the first piece of medical printing in New York. Zenger, who would later become famous for printing seditious texts, was instrumental in establishing freedom of the press in America. The Academy has the only known copy. Bound with our copy of the abstract is a copy of A Short treatise of the virtues of Dr. Bateman's Pectoral Drops, also issued by Okell and his printing house partners. Here, Batemans efficacy as a treatment for numerous ailments are described in sections dedicated to each. The last section of the treatise offers testimonials from satisfied customers.
